Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer

Aims: Retinoids are involved in cell growth, differentiation, and carcinogenesis. Their effects depend on cytosolic transport and binding to nuclear receptors. CRBP1 encodes a protein involved in this process. Because altered CRBP1 expression and promoter hypermethylation occur in several tumours, these changes were investigated in prostate tumorigenesis. Methods: The CRBP1 promoter was assessed by methylation specific polymerase chain reaction on tissue samples from 36 radical prostatectomy specimens (paired normal tissue, adenocarcinoma, and high grade prostatic intraepithelial neoplasia (HGPIN)), 32 benign prostatic hyperplasias (BPHs), and 13 normal prostate tissue samples from cystoprostatectomies. Methylation of DNA extracted from microdissected tissue was examined blindly. CRBP1 expression was assessed by immunohistochemistry on formalin fixed, paraffin wax embedded tissue. Results: Loss of CRBP1 expression was seen in 15 of 36 adenocarcinomas and 18 of 36 HGPINs. Fifteen adenocarcinomas and nine HGPINs showed overexpression, whereas the remainder showed normal expression. BPH displayed normal expression. No significant associations were found between CRBP1 expression and Gleason score or stage. CRBP1 promoter hypermethylation was found in 17 of 36 adenocarcinomas, three of 35 HGPINs, one of 36 normal prostate tissues from the same patients, none of 32 BPHs, and none of 13 normal prostate tissues from cystoprostatectomies. Loss of expression and hypermethylation of CRBP1 were not significantly associated. Conclusions: Altered CRBP1 expression and hypermethylation are common in prostate carcinoma, although CRBP1 hypermethylation is not an early event in tumorigenesis. Moreover, both adenocarcinoma and HGPIN show frequent CRBP1 overexpression. The molecular mechanisms underlying altered CRBP1 expression in prostate cancer deserve further study.

[1]  Paul Nurse,et al.  Basic Medical Research Award , 1998 .

[2]  C. Waldburger,et al.  Characterization of a New Member of the Fatty Acid-binding Protein Family That Binds All-trans-retinol* , 2001, The Journal of Biological Chemistry.

[3]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[4]  D. Sidransky,et al.  I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  M. Steiner Transforming growth factor-beta and prostate cancer. , 1995, World journal of urology.

[6]  D. Sidransky,et al.  Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. , 2001, Journal of the National Cancer Institute.

[7]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[8]  D. Bostwick,et al.  Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. , 1995, Cancer research.

[9]  D. Gleason,et al.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.

[10]  J. Oesterling,et al.  In Reply: RE:THE RELATIONSHIP BETWEEN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATE CANCER CRITICAL ISSUES , 1998 .

[11]  M. Sporn,et al.  Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. , 1996, Journal of the National Cancer Institute.

[12]  L. Gudas Retinoids and vertebrate development. , 1994, The Journal of biological chemistry.

[13]  A. Geinoz,et al.  Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. , 1997, The American journal of pathology.

[14]  I. Bleiweiss,et al.  Cellular retinol-binding protein expression and breast cancer. , 2000, Journal of the National Cancer Institute.

[15]  J. Herman,et al.  Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.

[16]  S. Lippman,et al.  Advances in the development of retinoids as chemopreventive agents. , 2000, The Journal of nutrition.

[17]  R. Lotan,et al.  Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  A. Ciechanover,et al.  Basic Medical Research Award. The ubiquitin system. , 2000, Nature medicine.

[19]  Qifeng Yang,et al.  Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. , 2001, The American journal of pathology.

[20]  F. Speleman,et al.  Assignment1 of the cellular retinol-binding protein 1 gene (RBP1) and of the coatomer beta` subunit gene (COPB2) to human chromosome band 3q23 by in situ hybridization , 1998, Cytogenetic and Genome Research.

[21]  L. Sobin,et al.  TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours , 2005 .

[22]  S. Clément,et al.  High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation , 2002, Virchows Archiv.

[23]  R. Dahiya,et al.  Chromosome 3p24‐26 and 3p22‐12 loss in human prostatic adenocarcinoma , 1997, International journal of cancer.

[24]  T. Motoyama,et al.  Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples , 2003, Oncogene.

[25]  Manel Esteller,et al.  Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. , 2002, Cancer research.

[26]  G. Gabbiani,et al.  Regulation of α‐smooth muscle actin and CRBP‐1 expression by retinoic acid and TGF‐β in cultured fibroblasts , 2001, Journal of cellular physiology.

[27]  Stephen J. Williams,et al.  Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  S. Nakajo,et al.  CRBP suppresses breast cancer cell survival and anchorage-independent growth , 2001, Oncogene.

[29]  P. Chambon A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Ottonello,et al.  Identification, retinoid binding, and x-ray analysis of a human retinol-binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Chambon,et al.  Cellular retinol‐binding protein I is essential for vitamin A homeostasis , 1999, The EMBO journal.

[34]  X-k Zhang,et al.  Vitamin A and apoptosis in prostate cancer. , 2002, Endocrine-related cancer.